Arcellx (ACLX) Equity Ratio (2021 - 2025)

Arcellx (ACLX) recorded quarterly Equity Ratio of 0.67 in Q4 2025, down 0.87% quarter-over-quarter from 0.67 in Q3 2025, and up 4.19% on a YoY basis from 0.64 in Q4 2024.

Arcellx (ACLX) Equity Ratio (2021 - 2025) Analysis & Trends

Arcellx's Equity Ratio history runs 5 years deep, the most recent figure standing at 0.67 for Q4 2025.

  • In Q4 2025, Equity Ratio rose 4.19% year-over-year to 0.67; the TTM figure through Dec 2025 stood at 0.67 (up 4.19% YoY), while the FY2025 annual figure was 0.67, up 4.19% from the prior year.
  • Equity Ratio was 0.67 for Q4 2025 at Arcellx, down from 0.67 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.92 in Q1 2022 to a low of 0.94 in Q4 2021.
  • Historically, Equity Ratio has averaged 0.47 across 5 years, with a median of 0.64 in 2024.
  • Biggest YoY gain for Equity Ratio was 190.07% in 2023; the steepest drop was 47.17% in 2023.
  • A 5-year view of Equity Ratio shows it stood at 0.94 in 2021, then surged by 30.78% to 0.65 in 2022, then soared by 190.07% to 0.59 in 2023, then climbed by 8.69% to 0.64 in 2024, then climbed by 4.19% to 0.67 in 2025.
  • The last three Equity Ratio figures came in at 0.67 (Q4 2025), 0.67 (Q3 2025), and 0.63 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 191.07
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 0.98
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 0.04
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.58
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 0.42
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.73
9 Abivax 91.96 Bn 91.96 Bn - 0.79
10 Arcellx 6.48 Bn 6.48 Bn - 0.67

Historic Data

Download Data
DateValue
Dec 31, 2025 0.67
Sep 30, 2025 0.67
Jun 30, 2025 0.63
Mar 31, 2025 0.64
Dec 31, 2024 0.64
Sep 30, 2024 0.63
Jun 30, 2024 0.66
Mar 31, 2024 0.64
Dec 31, 2023 0.59
Sep 30, 2023 0.43
Jun 30, 2023 0.47
Mar 31, 2023 0.49
Dec 31, 2022 -0.65
Sep 30, 2022 0.70
Jun 30, 2022 0.86
Mar 31, 2022 0.92
Dec 31, 2021 -0.94